Kidney Transplant Recipients Show Limited Lung Diffusion Capacity but Similar Hydrogen Peroxide Exhalation as Healthy Matched Volunteers: A Pilot Study
- PMID: 38002579
- PMCID: PMC10672367
- DOI: 10.3390/jcm12226964
Kidney Transplant Recipients Show Limited Lung Diffusion Capacity but Similar Hydrogen Peroxide Exhalation as Healthy Matched Volunteers: A Pilot Study
Abstract
Patients with end-stage chronic kidney disease show higher systemic oxidative stress and exhale more hydrogen peroxide (H2O2) than healthy controls. Kidney transplantation reduces oxidative stress and H2O2 production by blood polymorphonuclear leukocytes (PMNs). Kidney transplant recipients (KTRs) may be predisposed to an impairment of lung diffusing capacity due to chronic inflammation. Lung function and H2O2 concentration in the exhaled breath condensate (EBC) were compared in 20 KTRs with stable allograft function to 20 healthy matched controls. Serum interleukin eight (IL-8) and C-reactive protein (CRP), blood cell counts, and spirometry parameters did not differ between groups. However, KTRs showed lower total lung diffusing capacity for carbon monoxide, corrected for hemoglobin concentration (TLCOc), in comparison to healthy controls (92.1 ± 11.5% vs. 102.3 ± 11.9% of predicted, p = 0.009), but similar EBC H2O2 concentration (1.63 ± 0.52 vs. 1.77 ± 0.50 µmol/L, p = 0.30). The modality of pre-transplant renal replacement therapy had no effect on TLCOc and EBC H2O2. TLCOc did not correlate with time after transplantation. In this study, TLCOc was less reduced in KTRs in comparison to previous reports. We suggest this fact and the non-elevated H2O2 exhalation exhibited by KTRs, may result perhaps from the evolution of the immunosuppressive therapy.
Keywords: exhaled breath condensate; hydrogen peroxide; kidney transplantation; lung diffusing capacity; pulmonary function.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status.Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:557-564. doi: 10.2147/COPD.S187560. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30880945 Free PMC article.
-
Using the Inflammacheck Device to Measure the Level of Exhaled Breath Condensate Hydrogen Peroxide in Patients With Asthma and Chronic Obstructive Pulmonary Disease (The EXHALE Pilot Study): Protocol for a Cross-Sectional Feasibility Study.JMIR Res Protoc. 2018 Jan 30;7(1):e25. doi: 10.2196/resprot.8768. JMIR Res Protoc. 2018. PMID: 29382628 Free PMC article.
-
Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects.Free Radic Biol Med. 2001 Jan 15;30(2):178-86. doi: 10.1016/s0891-5849(00)00457-3. Free Radic Biol Med. 2001. PMID: 11163535 Clinical Trial.
-
[Exhaled breath condensate in the assessment of airway inflammation].Przegl Lek. 2006;63(12):1321-5. Przegl Lek. 2006. PMID: 17642149 Review. Polish.
-
Oxidative stress in COPD and its measurement through exhaled breath condensate.Clin Transl Sci. 2009 Apr;2(2):150-5. doi: 10.1111/j.1752-8062.2009.00093.x. Clin Transl Sci. 2009. PMID: 20443881 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous